Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

Corporate Governance

Chair
Member

Board Members

Director Name and Title Audit Committee Compensation Committee Nominating and Corporate Governance Committee

Robert E. George

Director

Michael D. Cannon

Director

Jacqueline Northcut

Director

Charter Documents